适应性有前途区域设计用于癌症免疫疗法,具有异质的延迟治疗效果
Bosheng Li1,2, Fangrong Yan1, Depeng Jiang2,3
1Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
Journal of biopharmaceutical statistics
|April 14, 2024
概括
这项研究引入了癌症免疫疗法试验的适应性设计,以解决延迟治疗效应. 新方法提高了统计能力和控制错误,提高了临床试验的效率.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 癌症免疫疗法癌症免疫疗法
背景情况:
- 癌症免疫疗法往往有延迟的效果,患者之间有所不同.
- 试验中的传统日志级别测试可能会失去功率,并使适应性设计的中间分析复杂化.
研究的目的:
- 为癌症免疫疗法试验提出适应性有前途区域设计,考虑到异质的延迟效应.
- 为临时分析提供条件功率计算和临界值调整方法.
主要方法:
- 利用带有随机延迟时间的断片比例危险模型来建模患者的存活率.
- 开发了一个适应性有前途区域设计,有三个区域 (不利,有前途,有利) 进行样本大小调整.
- 在中间分析时实施了对日志等级测试的临界值调整.
主要成果:
- 与固定样本设计相比,拟议的自适应设计显示出更大的整体功率.
- 该方法显示了与匹配组顺序试验相似的统计能力.
- 关键价值调整有效控制了I型错误率通货膨胀.
结论:
- 适应性有希望区设计是癌症免疫疗法试验的强大和高效的方法,其效果延迟.
- 提出的方法为临时决策和样本大小调整提供了可靠的解决方案.
- 为在未来的临床试验中实施这种方法提供了建议.
相关概念视频
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
01:30Cancer Vaccines
360
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K